BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8198936)

  • 1. Dose finding studies with imidapril--a new ACE inhibitor.
    Vandenburg MJ; Mackay EM; Dews I; Pullan T; Brugier S
    Br J Clin Pharmacol; 1994 Mar; 37(3):265-72. PubMed ID: 8198936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring.
    Palma-Gamiz JL; Pêgo M; Marquez E; Pujol M; Olivan J; Alegría E; Sagastagoitia-Gorostiza JD; Gonzalez-Juanatey JR
    Clin Drug Investig; 2007; 27(6):407-17. PubMed ID: 17506591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of imidapril in patients with essential hypertension: a double-blind comparison with captopril.
    Huang PJ; Chien KL; Chen MF; Lai LP; Chiang FT
    Cardiology; 2001; 95(3):146-50. PubMed ID: 11474160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, parallel-group study to compare the anti-hypertensive effects of imidapril and nifedipine in the treatment of mild-to-moderate essential hypertension.
    van der Does R; Euler R
    J Int Med Res; 2001; 29(3):154-62. PubMed ID: 11471852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single dose and steady state pharmacokinetics and pharmacodynamics of the ACE-inhibitor imidapril in hypertensive patients.
    Harder S; Thürmann PA; Ungethüm W
    Br J Clin Pharmacol; 1998 Apr; 45(4):377-80. PubMed ID: 9578185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 24-week dose-titration study of the angiotensin-converting enzyme inhibitor imidapril in the treatment of mild-to-moderate essential hypertension in the elderly.
    Dews I; VandenBurg M
    J Int Med Res; 2001; 29(2):100-7. PubMed ID: 11393342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cough-challenge trial with a new angiotensin-converting enzyme inhibitor, imidapril.
    Shionoiri H; Takasaki I; Minamisawa K; Ueda S; Kihara M; Shindo K; Hiroto S; Sugimoto K; Himeno H; Naruse M; Nagamochi I; Yasuda G
    J Clin Pharmacol; 1998 May; 38(5):442-6. PubMed ID: 9602958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-finding study of imidapril, a novel angiotensin converting enzyme inhibitor, in patients with stable chronic heart failure.
    Pinto YM; van Veldhuisen DJ; Tjon-Ka-Jie RT; Rooks G; Netzer T; Lie KI
    Eur J Clin Pharmacol; 1996; 50(4):265-8. PubMed ID: 8803516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril.
    van Veldhuisen DJ; Genth-Zotz S; Brouwer J; Boomsma F; Netzer T; Man In 'T Veld AJ; Pinto YM; Lie KI; Crijns HJ
    J Am Coll Cardiol; 1998 Dec; 32(7):1811-8. PubMed ID: 9857856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficiency and safety of ACE-inhibiting imidapril in patients with essential hypertension].
    Zweiker R; Stoschitzky K; Maier R; Klein W
    Acta Med Austriaca; 2002; 29(2):72-6. PubMed ID: 12050950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protection of the cardiovascular system by imidapril, a versatile angiotensin-converting enzyme inhibitor.
    Hosoya K; Ishimitsu T
    Cardiovasc Drug Rev; 2002; 20(2):93-110. PubMed ID: 12177688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imidapril hydrochloride in essential hypertension: a double-blind comparative study using enalapril maleate as a control.
    Saruta T; Omae T; Kuramochi M; Iimura O; Yoshinaga K; Abe K; Ishii M; Watanabe T; Takeda T; Ito K
    J Hypertens Suppl; 1995 Sep; 13(3):523-30. PubMed ID: 8592249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of imidapril therapy on endogenous fibrinolysis in patients with recent myocardial infarction.
    Soejima H; Ogawa H; Yasue H; Suefuji H; Kaikita K; Nishiyama K
    Clin Cardiol; 1997 May; 20(5):441-5. PubMed ID: 9134274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the angiotensin-converting enzyme inhibitor imidapril on reactive hyperemia in patients with essential hypertension: relationship between treatment periods and resistance artery endothelial function.
    Higashi Y; Sasaki S; Nakagawa K; Matsuura H; Kajiyama G; Oshima T
    J Am Coll Cardiol; 2001 Mar; 37(3):863-70. PubMed ID: 11693763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of imidapril in dipper and nondipper hypertensive patients: comparison between morning and evening administration.
    Kohno I; Ijiri H; Takusagawa M; Yin DF; Sano S; Ishihara T; Sawanobori T; Komori S; Tamura K
    Chronobiol Int; 2000 Mar; 17(2):209-19. PubMed ID: 10757465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of quality of life in a double-blind, randomized clinical trial of imidapril and captopril for hypertensive Chinese in Taiwan.
    Chien KL; Huang PJ; Chen MF; Chiang FT; Lai LP; Lee YT
    Cardiovasc Drugs Ther; 2002 May; 16(3):221-6. PubMed ID: 12374900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
    Fogari R; Zoppi A; Salvadeo SA; Mugellini A; Lazzari P; Santoro T; Derosa G
    Hypertens Res; 2011 Apr; 34(4):509-15. PubMed ID: 21179101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on angiotensin I converting enzyme (ACE): inhibitory effect of imidapril, a novel ACE inhibitor (II). Inhibition of various tissue ACEs ex vivo].
    Hashimoto Y; Kubo M; Sugaya T; Minobe S; Watanabe T; Yamamura M; Matsuoka Y
    Nihon Yakurigaku Zasshi; 1994 Jul; 104(1):51-61. PubMed ID: 8076891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue Angiotensin-converting enzyme activity plays an important role in pressure overload-induced cardiac fibrosis in rats.
    Kurosawa Y; Katoh M; Doi H; Narita H
    J Cardiovasc Pharmacol; 2002 Apr; 39(4):600-9. PubMed ID: 11904534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.